Skip to main content

Unable to load price data. Sorry.


Optimer Pharmaceuticals Inc (NASDAQ:OPTR.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:OPTR.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mamastox (44.54)
Submitted May 28, 2011

FDA approval for Dificid to treat gram positive( C-diff) bacteria, a potentially deadly superbug which causes,clostridium difficile associated diarreah. (CDAD ). This is an alternative drug to Vancomycin which has been the main antibiotic to treat… More

zzlangerhans (99.76)
Submitted March 02, 2013

Optimer stock is weathering yet another quarter of disappointing Dificid revenues by floating the old "strategic alternatives" flag. Sometimes the sale happens, more often that not it doesn't. I remember that tactic didn't work out very well for… More



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about OPTR.DL.

No one has written a Pitch for OPTR.DL stock yet. Tell us why you think OPTR.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in OPTR.DL.

No players have picked OPTR.DL yet. Tell us why you think OPTR.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for OPTR.DL.